$625M 0% convertible notes due 2031
Company: Core Scientific
The claim, verbatim
Issued $625 million 0% senior unsecured convertible notes maturing June 15, 2031, conversion price $22.49/share; holders may require repurchase December 15, 2027.
Source (primary)
Fourth Quarter Fiscal Year 2024 Earnings Presentation (IR page (investors.corescientific.com), ir_presentation)
View cached copy (2026-10-16)Live source ↗
Quote: “$625 million • 0% cash interest • None • June 15, 2031”
How we checked this
Checked on October 17, 2026. The cited source supports part of this claim, but not all of it.
The appendix gives the principal, rate, maturity and conversion price for the December convertible note. The December 15, 2027 repurchase right appears only once in a two-column table, and the extracted text does not show which of the two notes it applies to.
Confirmed in the source:
- Core Scientific issued $625 million of 0% senior unsecured convertible notes in Q4 2024
- The $625 million notes mature June 15, 2031
- The $625 million notes have a conversion price of $22.49 per share
We could not confirm this from the cited source:
- Holders of the $625 million notes may require repurchase on December 15, 2027
That does not mean it is false — only that this source does not establish it, as of the date above. If we find a source that settles it, we will re-check and update this page.
What we did: Read our cached copy of IR page (investors.corescientific.com) (https://d1io3yog0oux5.cloudfront.net/_b76ddaa46c59e7a64138659274ff5f32/corescientific/db/1066/11132/pdf/CORZ_Earnings_Presentation_Q4_2024.pdf) in full (26,814 characters, retrieved October 16, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Fourth Quarter Fiscal Year 2024 Earnings Presentation
Quote: “$625 million • 0% cash interest • None • June 15, 2031”